Less Ads, More Data, More Tools Register for FREE

Pin to quick picksColefax Grp. Regulatory News (CFX)

Share Price Information for Colefax Grp. (CFX)

Share Price is delayed by 15 minutes
Get Live Data
1,395.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 30.00 (2.174%)
Market Cap: £72.06m
CFX Live PriceLast checked at - London Stock Exchange

Intraday Colefax Grp. Share Chart

Tender Offer

27 Jan 2014 07:00

RNS Number : 5209Y
Colefax Group PLC
27 January 2014
 



THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE UNITED STATES OF AMERICA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

CFX

Colefax Group plc

("Colefax" or the "Company")

Tender Offer

Colefax today announces a proposed tender offer to buy up to approximately £4.4 million of ordinary shares of 10 pence each in the capital of the Company, representing 9 per cent. of the issued share capital of the Company. The Tender Offer is being implemented under the authority granted by Shareholders at the Company's Annual General Meeting held on 11 September 2012.

 

The Company has engaged Peel Hunt to implement the Tender Offer. Pursuant to the Tender Offer, Peel Hunt will purchase, as principal, up to a maximum of approximately 1.1 million Shares (being 9 per cent. of the Company's issued ordinary share capital).

 

A circular providing more information in relation to the Tender Offer and setting out the formal terms and conditions of the Tender Offer and Repurchase Agreement is expected to be posted to Eligible Shareholders (see below for definition) today.

 

Defined terms in this announcement are as those set out in the Circular.

 

Outline of the Tender Offer

 

The Tender Offer is being made at the lower of (i) 400 pence per Share; or (ii) 105 per cent. of the average closing mid-market price per Share as derived from the London Stock Exchange Daily Official List over the five business days immediately preceding 11 February 2014.

In accordance with the terms and conditions of the Repurchase Agreement, the Company has granted to Peel Hunt a put option under which Peel Hunt may require the Company to purchase, at the Tender Price, the Shares purchased by Peel Hunt pursuant to the Tender Offer. All of the Shares purchased by the Company pursuant to the Repurchase Agreement would be cancelled.

The purchase of Shares by the Company would be funded from available cash of the Company and would be paid out of the Company's distributable reserves. If the Tender Offer is taken up in full and the associated Repurchase is completed in full, the Company's distributable reserves would be reduced by the size of the Tender Offer.

 

The Company's issued ordinary share capital will be reduced to approximately 11.2 million Shares, assuming that: (i) the Tender Offer is taken up in full; (ii) the Repurchase Agreement is completed; and (iii) there is no change to the Company's issued ordinary share capital after 27 January 2014.

The Tender Offer is open to all shareholders on the Company's register of members at close of business on 7 February 2014 (the "Record Date") and who do not have a registered address in the United States of America, Canada, Australia or Japan ("Eligible Shareholders"). Peel Hunt, however, reserve the right, at their sole discretion, to extend the Tender Offer to shareholders that are not Eligible Shareholders where such extension will not constitute or give rise to a breach of applicable securities or other legal or regulatory requirements.

 

The Tender Offer is for up to 9% per cent. of the Company's issued share capital. Under the Tender Offer, each Eligible Shareholder is entitled to have up to 9% per cent. of his or her shareholding purchased by Peel Hunt at the Tender Price (the "Basic Entitlement"). Eligible Shareholders will be able to decide whether to tender none, some or all of their Shares within the overall limits of the Tender Offer. Tenders in excess of the Eligible Shareholder's Basic Entitlement will only be accepted to the extent that other Eligible Shareholders tender less than their Basic Entitlement or do not tender any Shares and will, if necessary, be scaled back on a pro rata basis (save for tenders from Eligible Shareholders who hold less than 1,000 Shares, whose tender will be accepted in full subject to there being capacity to purchase those Shares in accordance with the terms of the Tender Offer).

 

The Tender Offer is being made at a premium to the closing mid-market price on 24 January 2014 of 13.5 per cent.

 

Eligible Shareholders do not have to tender any Shares but, once submitted, a tender offer application form is irrevocable and cannot be withdrawn. Eligible Shareholders should note that, once tendered, Shares may not be sold, transferred, charged or otherwise disposed of.

 

The following Directors have informed the Company that they and their connected persons intend to tender the following number of Shares into the Tender Offer:

 

David Green

401,297

Rob Barker

23,013

Key Hall

18,135

Wendy Nicholls

48,776

 

In each case acceptance by the Company of an application under the Tender Offer in excess of 9% of the applicant's holding is subject to there being capacity to purchase those Shares in accordance with the terms of the Tender Offer.

 

Background to and reasons for the Tender Offer

 

The Company has built up distributable reserves of approximately £7.2 million and in line with the previous intention indicated by the Board, rather than buying back Shares on an ad hoc basis when they become available through the market, it would be appropriate to offer all Eligible Shareholders the opportunity to realise some of their investment in the Company by means of the Tender Offer.

 

A copy of the Circular has been submitted to the UK Listing Authority's National Storage Mechanism and will shortly be available at www.hemscott.com/nsm.do.

 

Full details of the Tender Offer are contained in the Circular which will shortly be available on the Company's investor relations website http://www.colefaxgroupplc.com/.

 

 

For further information:

 

Colefax Group plc

David Green, Chairman

Robert Barker, Finance Director

 

Tel: 020 7318 6000

Peel Hunt LLP

(NOMAD & Broker)

Dan Webster

Richard Brown

Matthew Armitt

 

 

Tel: 020 7418 8900

Biddicks

Katie Tzouliadis

Deborah Walter

 

Tel: 020 3178 6378

Peel Hunt LLP are acting for Colefax in relation to the Tender Offer and no one else and will not be responsible to anyone other than Colefax for providing the protections afforded to the customers of Peel Hunt LLP nor for providing any advice in relation to the Tender Offer.

This announcement does not constitute, or form part of, any offer for or invitation to sell or purchase any securities, or any solicitation of any offer for securities in any jurisdiction. Any acceptance or other response to the Tender Offer should be made only on the basis of information contained in or referred to in the Circular which will shortly be available on the Company's investor relations website http://www.colefaxgroupplc.com. The Circular will contain important information, including the full terms and conditions of the Tender Offer and how it may be accepted, which shareholders are urged to read carefully.

The Tender Offer is not being made in or into, and is not capable of acceptance in or from, The United States of America, Canada, Australia or Japan. Custodians, nominees and trustees should observe these restrictions and should not send or distribute documents in or into the United States of America, Canada, Australia or Japan.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEAEFLALELEAF
Date   Source Headline
2nd Jun 20267:00 amRNSResult of Share Buyback and TVR
28th May 20267:00 amRNSShare Buyback Launch
8th May 20267:00 amRNSFull Year Trading Update
10th Feb 20261:37 pmRNSTR-1 Notification
28th Jan 20267:00 amRNSHalf Year Results
30th Oct 20253:52 pmRNSTR-1 Notification
30th Oct 20253:38 pmRNSTR-1 Notification
30th Oct 20253:25 pmRNSTR-1 Notification
29th Oct 20251:59 pmRNSTR-1 Notification
28th Oct 20257:01 amRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSResult of Tender Offer, Purchase of Own Shares,TVR
13th Oct 20257:00 amRNSTender Offer
8th Oct 20251:03 pmRNSHolding(s) in Company
22nd Sep 20252:17 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
9th Sep 20252:28 pmRNSNotification of Transactions of Director
29th Jul 20257:00 amRNSPreliminary Results
3rd Feb 202512:48 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSHalf-year Results
27th Nov 20247:00 amRNSBoard Appointment
25th Oct 202412:16 pmRNSHolding(s) in Company
25th Oct 202411:18 amRNSDirector/PDMR Share Dealings
25th Oct 202411:08 amRNSHolding(s) in Company
24th Oct 20247:00 amRNSResult of Share Buyback
22nd Oct 20247:00 amRNSLaunch of Share Buyback Programme
26th Sep 20243:06 pmRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement
31st Jul 20247:00 amRNSPreliminary Results
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSInterim Results
2nd Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20232:59 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM Statement
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSResult of Tender Offer
1st Sep 20237:00 amRNSTender Offer
23rd Jan 20237:00 amRNSInterim Results
20th Dec 20223:27 pmRNSHolding(s) in Company
19th Oct 20225:21 pmRNSDirector/PDMR Shareholding
5th Oct 20224:55 pmRNSHolding(s) in Company
29th Sep 20223:22 pmRNSResult of AGM
29th Sep 20222:46 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSAGM Statement
26th Sep 20223:54 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
17th Aug 20227:00 amRNSPreliminary Results
21st Apr 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.